Dr. Eva Hassan Alsheik, MD

Dr. Alsheik practices at Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Alsheik's NPI, 1003078668, was assigned on June 25, 2008. Dr. Alsheik graduated from American University of the Caribbean School of Medicine in 2008. Dr. Alsheik's Pennsylvania license number on file is MD451072.

Dr. Alsheik's primary practice is Henry Ford Hospital, at 2799 W Grand Blvd, Detroit, MI 48202 in Wayne County. The practice phone is (313) 916-2600.

Dr. Alsheik's primary practice is Henry Ford Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Alsheik is also affiliated with Henry Ford West Bloomfield Hospital. The medical group on file is Henry Ford Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alsheik practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Alsheik's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Alsheik is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Alsheik's licenses on file in 2 states: Pennsylvania and Michigan.

Dmand AI lists acid reflux, colonoscopy, esophagus, stomach, or upper small intestine surgery, gastrointestinal bleeding, hemorrhoids, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Alsheik treats.

CMS data shows 230 Medicare services from Dr. Alsheik across 10 procedure codes in 2024, for 212 Medicare patients. Medicare paid $15,613 for them.

CMS counts 212 Medicare patients who saw Dr. Alsheik in 2024. The largest group is 65 to 74, with 94 patients. 72% of them have high cholesterol, and 67% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alsheik's median patient age at 62, with 74% women.

In 2024, Dr. Alsheik wrote 897 Medicare Part D claims for 189 patients. 71% of them were for generic drugs. CMS names the drug for 798 of them, across 26 drugs with 11 or more claims each, at $262,897 in total drug cost. In 2023, CMS named 1,176 claims across 29 drugs.

Dr. Alsheik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alsheik as offering telehealth. CMS counts 76 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Alsheik, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 11 papers to Dr. Alsheik, published from 2011 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Esophageal Achalasia, Esophageal Sphincter, Lower and Gastroenterology. Dr. Alsheik has published most often in Gastrointest Endosc. Dr. Alsheik's most frequent co-authors are Tobias Zuchelli, MD, Mouen A. Khashab, MD and Cyrus Ramin Piraka, MD.

CMS Open Payments shows 33 general payments to Dr. Alsheik from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 75% of the total. Enterra Medical, Inc. paid the most, $42,775.

Dr. Alsheik graduated from American University of the Caribbean School of Medicine in 2008.

Dr. Alsheik is in network with 14 carriers, including Aetna, Health Alliance Plan and Priority Health. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.